Skip to content

Analgesic Effect of Breast Feeding vs Sucrose in Neonatal Screening

Analgesic Effect of Breast Feeding vs Sucrose in Neonatal Screening

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00482560
Enrollment
100
Registered
2007-06-05
Start date
2007-01-31
Completion date
2007-04-30
Last updated
2007-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pain

Keywords

Sucrose, Breastfeeding, Heel lance

Brief summary

The purpose of this study is to compare the antinociceptive effect of 1 ml of 30% sucrose solution vs breastfeeding on neonatal screening heel lance

Detailed description

Blood sampling heel lance for neonatal screening is the most frequent painful manoeuvre in Neonatal Units in healthy neonates. Some techniques showed efficacy evidence in reducing pain response: sucrose solutions, breastfeeding during blood sampling, topical local anaesthetics. A Cochrane Review in 2004 recommends the administration of sucrose 0.24-0.48 g (1-2 ml of 24% sucrose solution). It reduces PIPP scale rate about 20%. Our purpose is to compare the antinociceptive effect of 1 ml 30% sucrose solution administered 2 minutes before heel lancing vs blood sampling heel lance during breastfeeding. PIPP scale is a validated 7-indicator scale for the assessment of procedural pain in preterm and term neonates. Informant consent was asked parents during consultation by a Pediatrician of the Neonatal Unit of the Hospital in the last months of pregnancy. After parent written consent was obtained, 100 three day old neonates were randomized for treatment A (breastfeeding) or B (sucrose solution administration). The nurse opened consecutively numbered envelopes. Timing of operators: Group A Breastfeeding * The heel of neonate was warmed up by a glove full of water at 40° C for 2 minutes. * Monitoring of Oxygen Saturation and Heart Rate. * The neonate was breastfed by the mother till the nurse watched a continuous active suction. * Administration of first phase of PIPP scale (15 seconds before heel lance). * Digital Voice Record started * Heel Lance with an automated piercing device . * Squeezing for blood sampling till filling 4 catch basins for neonatal screening. If necessary a new heel lance was practiced. * Administration of the second phase of PIPP scale. * Record of duration of blood sampling and collateral effects * Stop Digital Voice Recording Group B Sucrose administration * The neonate was laid on a baby-changing table. * The heel of neonate was warmed up by a gloves full of water a 40° C for 2 minutes. * Oral administration of 1 ml of 30% sucrose solution. * Monitoring of Oxygen Saturation and Heart Rate. * Administration of first phase of PIPP scale (15 seconds before heel lance). * Digital Voice Record starts * Heel Lance with an automated piercing device. * Squeezing for blood sampling till filling 4 catch basins for neonatal screening. If necessary a new heel lance was practiced. * Administration of the second phase of PIPP scale.Record of duration of blood sampling and collateral effects. * Stop Digital Voice Recording Blood sampling was practiced by skilled pediatric nurses. Registration of data, PIPP scale, voice record was made by a second operator, blind to the pur pose of the study. A third blind operator collected paper data and checked voice record (outcome cry behaviour).

Interventions

DRUGSucrose solution 30%1 ml
BEHAVIORALBreastfeeding

Sponsors

Agnelli Hospital, Italy
CollaboratorOTHER
University of Turin, Italy
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
2 Days to 5 Days
Healthy volunteers
No

Inclusion criteria

* Term neonates, gestational age 37-42 weeks * Apgar \>= 7 * Not fed in the last 30 minutes * Informant consent

Exclusion criteria

* Congenital malformation * Born in Caesarian Section in General Anaesthesia * Maternal use of opioids * Administration of Naloxone, Phenobarbital in the previous 48 hours * Impossibility of breastfeeding

Design outcomes

Primary

MeasureTime frame
Premature Infant Pain Profile (PIPP) scale rate (0-21)15 seconds before and Within 30 seconds after heel lance

Secondary

MeasureTime frame
Heart Rate Increasewithin 30 seconds after heel lance
Oxygen Saturation decreasewithin 30 seconds after heel lance
Duration of first crywithin 2 minutes after heel lance
Percentage of crying timewithin 2 minutes after heel lance

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026